Synonyms: BAY885 | compound 41 [PMID: 30563338]
Compound class:
Synthetic organic
Comment: BAY-885 is a tool compound for studying the function of ERK5 (MAPK7) in cellular signalling, particularly its role in cancer cell proliferation [1]. The compound has been used to show that pharmacological inhibition of ERK5 does not recapitulate the antiproliferative effects observed with genetic depletion of ERK5, findings which cast doubt on the role of ERK5 as a therapeutic target for cancer cell growth.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
BAY-885 shows no inhibition of CYP enzymes (up to 20 μM) or hERG (up to 10 μM), and in contrast to earlier ERK5 inhibitors (e.g. XMD8-92) does not bind BRD4 (up to 20 μM) [1]. In a commercial kinase screening panel rat Fer and human EphB3 and EphA5 kinases were inhibited by 62%, 58%, and 43%, respectively, and all other tested kinases were inhibited by ≤20% [1]. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|